BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/28/2024 2:21:56 AM | Browse: 52 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 91786
Country Greece
Category Oncology
Manuscript Type Editorial
Article Title Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies
Manuscript Source Invited Manuscript
All Author List Grigorios Christodoulidis, Marina Nektaria Kouliou and Konstantinos Eleftherios Koumarelas
Funding Agency and Grant Number
Corresponding Author Grigorios Christodoulidis, MD, PhD, Academic Editor, Department of General Surgery, University Hospital of Larissa, University of Thessaly, Biopolis Campus, Larissa 41110, Greece. gregsurg09@gmail.com
Key Words Autoimmune pancreatitis; Immunoglobulin G4-related disease; Pancreatic cancer; Surgery
Core Tip Autoimmune pancreatitis (AIP) is a unique form of pancreatitis, categorized into AIP-1 and AIP-2, with distinct clinical characteristics and associations. AIP-1, linked to elevated immunoglobulin G4 (IgG4) levels, exhibits higher relapse rates and predominantly affects older males, while AIP-2 is less common and associated with inflammatory bowel disease. Recognized as a manifestation of IgG4-related systemic disease, AIP poses an increased risk of malignancies, especially gastric, colorectal, and bladder cancers. Despite ongoing debates about the association with pancreatic cancer, careful diagnostic evaluation, including biopsy and response to steroids, is crucial for informed decision-making regarding surgery. AIP patients may have concurrent PanINs but generally experience better long-term outcomes compared to pancreatic cancer patients. Steroids remain the primary treatment, and emerging biomarkers like interferon alpha and interleukin-33 offer promising avenues for monitoring and managing AIP.
Citation Christodoulidis G, Kouliou MN, Koumarelas KE. Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies. World J Gastroenterol 2024; 30 (15):2091-2095
Received
2024-01-05 09:42
Peer-Review Started
2024-01-05 09:42
To Make the First Decision
Return for Revision
2024-01-15 03:41
Revised
2024-01-24 16:39
Second Decision
2024-03-28 01:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-03-28 02:21
Articles in Press
2024-03-28 02:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-04-07 23:01
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com